Tasso, Inc.

Tasso, Inc.

Life-changing, actionable insights. We are revolutionizing blood collection.

Founded 2014

Seattle, United States 112 employees Series B Total: $135.58M Health Care, Health and Wellness

Tasso, Inc. is a Seattle-based startup providing life-changing, actionable insights in the health care industry. Founded in 2011, the company focuses on at-home diagnostic testing, revolutionizing blood collection with a goal to make clinical-grade, convenient diagnostic tests accessible to a wide range of users. Its innovative approach has gained traction with leading health systems, clinical research organizations, and academic medical centers. Tasso's product has been utilized in pharmaceutical clinical trials, by Olympians for a virtual anti-doping program, and adopted broadly by hospital systems across the US. The company received a significant $100.00M Series B investment on 16 December 2021. This investment was backed by prominent names in the investment world, including RA Capital Management, The Cedars-Sinai Accelerator, Senvest Capital, D. E. Shaw, Foresite Capital, InCube Ventures, J2 Ventures, SIB Innovations- und Beteiligungsgesellschaft, Hambrecht Ducera Growth Ventures, and the Merck Global Health Innovation Fund. Tasso's focus on disruptive innovation in the health care industry, backed by significant investments from renowned firms, positions it as a key player in the evolving landscape of at-home diagnostic testing.

Funding Stage	Amount	Investors	Lead Investors	Date
Series B	$100.00M	10	RA Capital Management, The Cedars-Sinai Accelerator +8	16 Dec 2021
Series A	$17.00M	5	The Cedars-Sinai Accelerator, Foresite Capital +3	22 Jul 2020
Series A	$6.10M	3	Techstars, Vertical Venture Partners +1	05 Mar 2019
Seed Round	Undisclosed	1	MedTech Innovator	12 Jun 2018
Grant	$230.00K	-		21 Sep 2017
Pre Seed Round	Undisclosed	2	Techstars, The Cedars-Sinai Accelerator	01 Sep 2017
Grant	$6.00M	2	NIMHD, Defense Threat Reduction Agency (DTRA)	15 Aug 2017
Grant	$200.00K	-		09 Jun 2016
Grant	Undisclosed	-		01 Sep 2015
Grant	$5.50M	-		08 Feb 2014

Funding Stage

Amount

Investors

Lead Investors

Date

Series B

$100.00M

RA Capital Management, The Cedars-Sinai Accelerator +8

16 Dec 2021

Series A

$17.00M

The Cedars-Sinai Accelerator, Foresite Capital +3

22 Jul 2020

Series A

$6.10M

Techstars, Vertical Venture Partners +1

05 Mar 2019

Seed Round

Undisclosed

MedTech Innovator

12 Jun 2018

Grant

$230.00K

21 Sep 2017

Pre Seed Round

Undisclosed

Techstars, The Cedars-Sinai Accelerator

01 Sep 2017

Grant

$6.00M

NIMHD, Defense Threat Reduction Agency (DTRA)

15 Aug 2017

Grant

$200.00K

09 Jun 2016

Grant

Undisclosed

01 Sep 2015

Grant

$5.50M

08 Feb 2014

FAQ About Tasso, Inc.

Life-changing, actionable insights. We are revolutionizing blood collection.

Tasso, Inc. was founded in 2014.

Tasso, Inc. is headquartered in Seattle, United States.

Tasso, Inc. operates in Health Care and Health and Wellness. Its work centres on At-home diagnostic testing, Blood collection, Diagnostic tests and Biotech.

Tasso, Inc. has approximately 112 employees.

Tasso, Inc. has completed 12 funding rounds, raising a total of $135.58M. The latest funding stage is Series B.

Top alternatives and competitors to Tasso, Inc. include YorkTest Laboratories, cerascreen, Drug Free Sport International, uBiome, Micro Therapeutic Research Labs Private Limited. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Tasso, Inc. and YorkTest Laboratories are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About Tasso, Inc.

Funding Rounds & Investors (12)

Tasso, Inc. Alternatives & Competitors

FAQ About Tasso, Inc.